Literature DB >> 2917391

Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium.

J M Davidenko1, L Cohen, R Goodrow, C Antzelevitch.   

Abstract

Early afterdepolarization (EAD)-induced triggered activity is thought to contribute to the cardiac arrhythmogenic effects of several class I antiarrhythmic agents. The combination of quinidine therapy, bradycardia, and hypokalemia is known to predispose to torsade de pointes, which is a form of atypical polymorphous ventricular tachycardia commonly associated with long QT intervals. Recent clinical reports have shown suppression of quinidine-induced torsade de pointes with intravenous administration of magnesium sulfate. To provide further understanding of these relations, we used standard microelectrode techniques to examine the time course of quinidine-induced action potential prolongation, EAD, and triggered activity development and the dependence of these changes on [K+]0, [Mg2+]0, and stimulation frequency in isolated Purkinje fiber preparations exposed to low concentrations of the drug. At slow stimulation rates, the quinidine-induced increase of action potential duration was slow to develop and failed to reach a steady state after 3 hours of exposure to the drug. EAD and EAD-induced triggered activity generally became apparent 70-90 minutes after adding the drug. Quinidine produced triggered activity in 10 of 22 preparations superfused with Tyrode's solution containing normal [K+]0 (3.5-4.0 mM) and in six other preparations when [K+]0 was reduced. In the presence of normal [K+]0, two types of EAD and triggered activity were distinguished. In four of 10 preparations, this activity arose from phase 2 of the action potential; in eight of 10, it was associated with phase 3; and in two experiments, both types were present in the same preparation. The incidence of both forms of triggered responses depended greatly on the rate of stimulation. Triggered activity arising from phase 3 was always manifest at rates considerably slower than those giving rise to phase 2 activity. Both forms of triggered activity were sensitive to changes in the extracellular concentration of potassium and magnesium. Lower-than-normal levels of these electrolytes facilitated the manifestation of triggered activity, whereas elevated levels suppressed or caused a shift in the frequency-dependence of the activity. Phase 2, but not phase 3, EADs were abolished in response to increased [Mg2+]0. The data show a clear congruity between the conditions that predispose to torsade de pointes in the clinic and the conditions under which quinidine may induce triggered activity and marked action potential prolongation in isolated Purkinje fibers.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2917391     DOI: 10.1161/01.cir.79.3.674

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  36 in total

1.  Field and action potential recordings in heart slices: correlation with established in vitro and in vivo models.

Authors:  Herbert M Himmel; Alexandra Bussek; Michael Hoffmann; Rolf Beckmann; Horst Lohmann; Matthias Schmidt; Erich Wettwer
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Torsades de Pointes.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-08

3.  Genesis of phase 3 early afterdepolarizations and triggered activity in acquired long-QT syndrome.

Authors:  Mitsunori Maruyama; Shien-Fong Lin; Yuanfang Xie; Su-Kiat Chua; Boyoung Joung; Seongwook Han; Tetsuji Shinohara; Mark J Shen; Zhilin Qu; James N Weiss; Peng-Sheng Chen
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-11-15

Review 4.  Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.

Authors:  Russell A Wilke; Debbie W Lin; Dan M Roden; Paul B Watkins; David Flockhart; Issam Zineh; Kathleen M Giacomini; Ronald M Krauss
Journal:  Nat Rev Drug Discov       Date:  2007-11       Impact factor: 84.694

Review 5.  Possible pharmacological actions of magnesium in acute myocardial infarction.

Authors:  K L Woods
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

6.  Diversity of early afterdepolarizations in guinea pig myocytes: spatial characteristics of intracellular Ca2+ concentration.

Authors:  M Miura; N Ishide; H Numaguchi; T Takishima
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

7.  An experimental model of the production of early after depolarizations by injury current from an ischemic region.

Authors:  R Kumar; R W Joyner
Journal:  Pflugers Arch       Date:  1994-10       Impact factor: 3.657

8.  Facts, fancies and follies of drug-induced QT/QTc interval shortening.

Authors:  Marek Malik
Journal:  Br J Pharmacol       Date:  2010-01       Impact factor: 8.739

Review 9.  [Medicamentous anti-arrhythmia therapy. Is oral adjuvant therapy with electrolytes of value?].

Authors:  R Haberl
Journal:  Herz       Date:  1997-06       Impact factor: 1.443

Review 10.  Molecular genetic aspects of the Romano-Ward long QT syndrome.

Authors:  J A Towbin
Journal:  Tex Heart Inst J       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.